MDGL logo

Madrigal Pharmaceuticals
MDGL

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$13.56B
EV
$12.79B
Shares Outstanding
23.53M
Beta
-1.05
Industry
Biotechnology

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
15
P/E 2025E
-
P/Revenue 2025E
14.28x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2025E
93.55%
Net Profit Margin 2025E
-23.20%
ROE 2025E
-32.06%
ROCE 2024
-80.35%

Dividends

DPS 2025E
$0.00
Payout Ratio 2025E
0.00%
Div. Yield 2025E
0.00%
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Madrigal Pharmaceuticals, Inc.

gainify
MDGL logo

Madrigal Pharmaceuticals, Inc.

MDGL

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid ho...

Sector

Healthcare

Industry

Biotechnology

CEO

Sibold, William

Employees

528

IPO Date

2007-02-06

Headquarters

Four Tower Bridge, Suite 200, 200 Barr Harbor Drive, West Conshohocken, Pennsylvania, 19428, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.